Louisiana Clears Hospital Cannabis Access for Terminally Ill Patients

For patients admitted to Louisiana hospitals under a terminal diagnosis, a valid medical cannabis prescription has carried a frustrating footnote: legal under state law, but practically inaccessible inside an inpatient facility. The Louisiana Legislature voted to close that gap on May 19, 2026, passing a bill that requires licensed healthcare facilities to accommodate on-site cannabis use for qualifying terminally ill patients and sending it to Gov. Jeff Landry’s desk.

Senate Bill 270, sponsored by Sen. Katrina Jackson-Andrews (D), cleared the House 53-45 after the Senate passed it 33-2 on April 8, 2026. If Landry signs it, the law takes effect August 1, 2026.

What the Law Would Require

Under the legislation, any licensed inpatient healthcare facility must allow patients with terminal and irreversible conditions to use medical cannabis on-site, provided they hold a current physician recommendation. The qualifying standard tracks Louisiana’s existing Natural Death Act definition for end-of-life conditions. Emergency departments, outpatient units, and behavioral health facilities are carved out.

The bill places the full operational responsibility on the patient’s side. The patient or their primary caregiver must acquire cannabis through Louisiana’s existing state-regulated program, administer it themselves, and remove any remaining supply at discharge. Hospital staff — physicians, nurses, and pharmacists — are explicitly prohibited from administering, storing, retrieving, or assisting with the cannabis in any way. Facilities must document cannabis use in the patient’s medical record, require the cannabis to be kept in a locked container the patient supplies, and develop written guidelines with staff training.

Smoking and vaping are prohibited. The bill limits on-site use to other consumption forms — the tinctures, oils, capsules, and similar products that the state’s Louisiana Department of Health-licensed retailers already carry as their standard catalog.

“When a patient is in pain and they believe that therapeutic marijuana will work and have a prescription for it,” Jackson-Andrews told the Senate, “it allows them to have that prescription delivered to the hospital and administered by one of their family members or themselves.”

The Federal Fault Line

The most consequential design decision in the bill is a statewide collective opt-out clause developed with the Louisiana Hospital Association. It addresses the compliance tension that has effectively kept hospitals out of this space: state law would require accommodation, but the Centers for Medicare and Medicaid Services conditions of participation could, in theory, expose facilities to federal funding consequences for hosting cannabis on-site.

The bill makes compliance contingent on federal posture. If the Department of Justice, a federal regulatory agency, or CMS initiates enforcement action against any Louisiana healthcare facility over the state cannabis policy — or issues guidance expressly prohibiting on-site use in healthcare settings — then all Louisiana healthcare facilities may suspend compliance until the pressure lifts. Notably, the opt-out extends statewide: a facility not directly targeted can still pause compliance if the federal action is taken against any facility in the state.

The bill also specifies that a facility cannot deny a patient cannabis access solely because marijuana remains a federally controlled substance. That provision addresses what has functioned as the standing justification for hospitals declining to accommodate medical cannabis patients: not active federal enforcement pressure, but the federal classification itself. Under the bill, that classification alone no longer qualifies as sufficient grounds to refuse a qualifying patient.

Facilities are not required to recommend cannabis to patients or include it in discharge plans, and compliance is not a condition for obtaining or renewing a healthcare facility license.

What Landry Decides

Louisiana has run a state-regulated therapeutic marijuana program since 2015. The Louisiana Department of Health assumed regulatory authority over the program in 2022, and its Cannabis Program fully took over oversight of marijuana retailers from the Board of Pharmacy at the start of 2025. Any Louisiana-licensed physician in good standing can recommend medical cannabis within a standard doctor-patient relationship.

Despite a decade-long program, inpatient hospital settings have remained a gap — one that this legislation closes specifically for patients at the end of their lives. The near-unanimous Senate vote and a 10-0 House committee result signal strong support among legislators most focused on health policy; the 53-45 full House margin shows broader resistance in the chamber, though still a comfortable passage.

Gov. Landry has not publicly indicated whether he will sign or veto the measure. If enacted, healthcare facilities would have roughly ten weeks between a signing and the August 1, 2026, effective date to put written guidelines, training protocols, and intake procedures in place — frameworks that essentially no Louisiana hospital currently has.

How the policy works in practice, and whether any federal enforcement activity triggers the collective opt-out before the rules take root, will be the tests that follow.